Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Geriatrics Reports
Published in: Current Geriatrics Reports 3/2016

01-09-2016 | Physical Therapy and Rehabilitation (O Addison, Section Editor)

Exercise in Type 2 Diabetic Peripheral Neuropathy

Authors: Arwen A. Fuller, J. Robinson Singleton, A. Gordon Smith, Robin L. Marcus

Published in: Current Geriatrics Reports | Issue 3/2016

Login to get access

Abstract

Approximately half of all patients with type 2 diabetes develop peripheral neuropathy, which contributes to functional decline and significantly reduces quality of life. Type 2 diabetes and consequent diabetic peripheral neuropathy share several pathogenic mechanisms and are both positively influenced by increased physical activity and exercise even prior to disease diagnosis. Successful exercise interventions in individuals with diabetic peripheral neuropathy have employed continuous endurance, resistance, balance and agility, and high-intensity interval training protocols and have been associated with improvement in stability, gait, sensory function, nerve regeneration rates, pain, mood, and quality of life. Recent evidence has shown no increased prevalence of foot trauma in those with diabetic peripheral neuropathy suggesting that weight-bearing exercise is safe in the absence of active ulceration. While exercise is often associated with improved glycemic control, several studies suggest improvement in neuropathy is independent of improved glycemic control or weight reduction, suggesting other metabolic effects, or exercise-related physiologic changes are important.
Literature
1.
Corriveau H et al. Evaluation of postural stability in elderly with diabetic neuropathy. Diabetes Care. 2000;23(8):1187–91.PubMedCrossRef
2.
Gordois A et al. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care. 2003;26(6):1790–5.PubMedCrossRef
3.
Mueller MJ et al. Insensitivity, limited joint mobility, and plantar ulcers in patients with diabetes mellitus. Phys Ther. 1989;69(6):453–9. discussion 459–62.PubMed
4.••
Singleton JR et al. Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients. Ann Neurol. 2015;77(1):146–53. Exercise induced changes in metabolic syndrome features affect changes in cutaneous regenerative capacity. PubMedCrossRef
5.
6.
Dubois SG et al. Decreased expression of adipogenic genes in obese subjects with type 2 diabetes. Obesity (Silver Spring). 2006;14(9):1543–52.CrossRef
7.
Pasarica M et al. Differential effect of weight loss on adipocyte size subfractions in patients with type 2 diabetes. Obesity (Silver Spring). 2009;17(10):1976–8.CrossRef
8.
Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond). 2009;33(1):54–66.CrossRef
9.
Zhou QG et al. Advanced oxidation protein products induce inflammatory response and insulin resistance in cultured adipocytes via induction of endoplasmic reticulum stress. Cell Physiol Biochem. 2010;26(4–5):775–86.PubMedCrossRef
10.
Mootha VK et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267–73.PubMedCrossRef
11.
12.
Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307(5708):384–7.PubMedCrossRef
13.
DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992;15(3):318–68.PubMedCrossRef
14.
Gulli G et al. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes. 1992;41(12):1575–86.PubMedCrossRef
15.
Vaag A, Henriksen JE, Beck-Nielsen H. Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1992;89(3):782–8.PubMedPubMedCentralCrossRef
16.
Weyer C et al. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest. 1999;104(6):787–94.PubMedPubMedCentralCrossRef
17.
Kim B et al. Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer’s disease. J Alzheimers Dis. 2013;34(3):727–39.PubMed
18.
19.
20.
Vincent AM et al. Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy. Acta Neuropathol. 2010;120(4):477–89.PubMedPubMedCentralCrossRef
21.
22.
Bays HE. Adiposopathy is “sick fat” a cardiovascular disease? J Am Coll Cardiol. 2011;57(25):2461–73.PubMedCrossRef
23.
Wong KL et al. Palmitic acid-induced lipotoxicity and protection by (+)-catechin in rat cortical astrocytes. Pharmacol Rep. 2014;66(6):1106–13.PubMedCrossRef
24.
Pratipanawatr W et al. Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation. Diabetes. 2001;50(11):2572–8.PubMedCrossRef
25.
Petersen KF, Dufour S, Shulman GI. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med. 2005;2(9):e233.PubMedPubMedCentralCrossRef
26.
Kashyap SR et al. Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes. Am J Physiol Endocrinol Metab. 2004;287(3):E537–46.PubMedCrossRef
27.
Goodpaster BH, Thaete FL, Kelley DE. Composition of skeletal muscle evaluated with computed tomography. Ann N Y Acad Sci. 2000;904:18–24.PubMedCrossRef
28.
Bittel AJ et al. Explanators of sarcopenia in individuals with diabesity: a cross-sectional analysis. J Geriatr Phys Ther. 2015 [Epub ahead of print].
29.
Hilton TN et al. Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function. Phys Ther. 2008;88(11):1336–44.PubMedPubMedCentralCrossRef
30.
Tuttle LJ, Hastings MK, Mueller MJ. A moderate-intensity weight-bearing exercise program for a person with type 2 diabetes and peripheral neuropathy. Phys Ther. 2012;92(1):133–41.PubMedCrossRef
31.
Tuttle LJ et al. Lower physical activity is associated with higher intermuscular adipose tissue in people with type 2 diabetes and peripheral neuropathy. Phys Ther. 2011;91(6):923–30.PubMedPubMedCentralCrossRef
32.
Sugimoto K, Yasujima M, Yagihashi S. Role of advanced glycation end products in diabetic neuropathy. Curr Pharm Des. 2008;14(10):953–61.PubMedCrossRef
33.
Juranek JK et al. Increased expression of the receptor for advanced glycation end-products in human peripheral neuropathies. Brain Behav. 2013;3(6):701–9.PubMedPubMedCentralCrossRef
34.
35.
36.
Yoo M et al. Pilot study of exercise therapy on painful diabetic peripheral neuropathy. Pain Med. 2015;16(8):1482–9.PubMedCrossRef
37.
38.
39.
Ziegler D et al. Near-normoglycaemia and development of neuropathy: a 24-year prospective study from diagnosis of type 1 diabetes. BMJ Open. 2015;5(6):e006559.PubMedPubMedCentralCrossRef
40.
Kennedy JM, Zochodne DW. Impaired peripheral nerve regeneration in diabetes mellitus. J Peripher Nerv Syst. 2005;10(2):144–57.PubMedCrossRef
41.
Griffin JW, Thompson WJ. Biology and pathology of nonmyelinating Schwann cells. Glia. 2008;56(14):1518–31.PubMedCrossRef
42.
Tesfaye S et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285–93.PubMedPubMedCentralCrossRef
43.
Kaprio J et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia. 1992;35(11):1060–7.PubMedCrossRef
44.
Groop L et al. Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes. 1996;45(11):1585–93.PubMedCrossRef
45.
46.
47.
Weinstein AR et al. Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA. 2004;292(10):1188–94.PubMedCrossRef
48.
49.
Al-Kaabi, J, Maskari, FA, Zoubeidi, T, Abdulle, A, Shah, SM. Prevalence and determinants of peripheral neuropathy in patients with type 2 diabetes attending a tertiary care center in the United Arab Emirates. J Diabetes Metab, 2014;5(346). doi:10.​4172/​2155-6156.​1000346.
50.
Diabetes Prevention Program Research, G et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677–86.CrossRef
51.
Tuomilehto J et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.PubMedCrossRef
52.
Pan XR et al. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care. 1997;20(11):1664–9.PubMedCrossRef
53.
Balducci S et al. Exercise training can modify the natural history of diabetic peripheral neuropathy. J Diabetes Complications. 2006;20(4):216–23.PubMedCrossRef
54.
Smith AG et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006;29(6):1294–9.PubMedCrossRef
55.••
Kluding PM et al. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complications. 2012;26(5):424–9. Describes changes in neuropathic and cutaneous nerve fiber branching following exercise in persons with diabetic peripheral neuropathy. PubMedPubMedCentralCrossRef
56.
Morrison S et al. Exercise improves gait, reaction time and postural stability in older adults with type 2 diabetes and neuropathy. J Diabetes Complications. 2014;28(5):715–22.PubMedCrossRef
57.••
Dixit S, Maiya AG, Shastry BA. Effect of aerobic exercise on peripheral nerve functions of population with diabetic peripheral neuropathy in type 2 diabetes: a single blind, parallel group randomized controlled trial. J Diabetes Complications. 2014;28(3):332–9. Compares moderate intensity aerobic exercise and standard care on nerve conduction velocity and Michigan Diabetic Neuropathy Score. PubMedCrossRef
58.
Ahn S, Song R. Effects of Tai Chi exercise on glucose control, neuropathy scores, balance, and quality of life in patients with type 2 diabetes and neuropathy. J Altern Complement Med. 2012;18(12):1172–8.PubMedPubMedCentralCrossRef
59.
Healy GN et al. Objectively measured sedentary time, physical activity, and metabolic risk: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Diabetes Care. 2008;31(2):369–71.PubMedCrossRef
60.
Mueller MJ et al. Weight-bearing versus nonweight-bearing exercise for persons with diabetes and peripheral neuropathy: a randomized controlled trial. Arch Phys Med Rehabil. 2013;94(5):829–38.PubMedCrossRef
61.
Lemaster JW et al. Daily weight-bearing activity does not increase the risk of diabetic foot ulcers. Med Sci Sports Exerc. 2003;35(7):1093–9.PubMedCrossRef
62.
Lemaster JW et al. Effect of weight-bearing activity on foot ulcer incidence in people with diabetic peripheral neuropathy: feet first randomized controlled trial. Phys Ther. 2008;88(11):1385–98.PubMedCrossRef
63.
Mueller MJ, Maluf KS. Tissue adaptation to physical stress: a proposed “physical stress theory” to guide physical therapist practice, education, and research. Phys Ther. 2002;82(4):383–403.PubMed
64.
Maluf KS, Mueller MJ. Novel Award 2002. Comparison of physical activity and cumulative plantar tissue stress among subjects with and without diabetes mellitus and a history of recurrent plantar ulcers. Clin Biomech (Bristol, Avon). 2003;18(7):567–75.CrossRef
65.
Armstrong DG et al. Variability in activity may precede diabetic foot ulceration. Diabetes Care. 2004;27(8):1980–4.PubMedCrossRef
66.
Hu FB et al. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA. 2003;289(14):1785–91.PubMedCrossRef
67.
Barone Gibbs B et al. Reducing sedentary behavior versus increasing moderate-to-vigorous intensity physical activity in older adults: a 12-week randomized, clinical trial. J Aging Health. 2016 [Epub ahead of print].
68.
Boucher P et al. Postural stability in diabetic polyneuropathy. Diabetes Care. 1995;18(5):638–45.PubMedCrossRef
69.
Menz HB et al. Walking stability and sensorimotor function in older people with diabetic peripheral neuropathy. Arch Phys Med Rehabil. 2004;85(2):245–52.PubMedCrossRef
70.
Pan X, Bai J. Balance training in the intervention of fall risk in elderly with diabetic peripheral neuropathy: a review. Int J Nurs Sci. 2014;1(4):441–5.
71.
Gregg EW et al. Diabetes and physical disability among older U.S. adults. Diabetes Care. 2000;23(9):1272–7.PubMedCrossRef
72.
Miller DK et al. Reported and measured physical functioning in older inner-city diabetic African Americans. J Gerontol A Biol Sci Med Sci. 1999;54(5):M230–6.PubMedCrossRef
73.
DeMott TK et al. Falls and gait characteristics among older persons with peripheral neuropathy. Am J Phys Med Rehabil. 2007;86(2):125–32.PubMedCrossRef
74.
Cavanagh PR et al. Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus. Diabet Med. 1992;9(5):469–74.PubMedCrossRef
75.
Lee K, Lee S, Song C. Whole-body vibration training improves balance, muscle strength and glycosylated hemoglobin in elderly patients with diabetic neuropathy. Tohoku J Exp Med. 2013;231(4):305–14.PubMedCrossRef
76.
Akbari M et al. Do diabetic neuropathy patients benefit from balance training? J Rehabil Res Dev. 2012;49(2):333–8.PubMedCrossRef
77.
Song CH et al. Effects of an exercise program on balance and trunk proprioception in older adults with diabetic neuropathies. Diabetes Technol Ther. 2011;13(8):803–11.PubMedCrossRef
78.
Allet L et al. The gait and balance of patients with diabetes can be improved: a randomised controlled trial. Diabetologia. 2010;53(3):458–66.PubMedCrossRef
79.
Richardson JK, Sandman D, Vela S. A focused exercise regimen improves clinical measures of balance in patients with peripheral neuropathy. Arch Phys Med Rehabil. 2001;82(2):205–9.PubMedCrossRef
80.
Kelley DE, Goodpaster BH. Effects of physical activity on insulin action and glucose tolerance in obesity. Med Sci Sports Exerc. 1999;31(11 Suppl):S619–23.PubMedCrossRef
81.
82.
Mandroukas K et al. Physical training in obese women. Effects of muscle morphology, biochemistry and function. Eur J Appl Physiol Occup Physiol. 1984;52(4):355–61.PubMedCrossRef
83.
Adamopoulos S et al. Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J. 2001;22(9):791–7.PubMedCrossRef
84.
Menshikova EV et al. Effects of exercise on mitochondrial content and function in aging human skeletal muscle. J Gerontol A Biol Sci Med Sci. 2006;61(6):534–40.PubMedPubMedCentralCrossRef
85.
Talanian JL et al. Two weeks of high-intensity aerobic interval training increases the capacity for fat oxidation during exercise in women. J Appl Physiol (1985). 2007;102(4):1439–47.CrossRef
86.
Dunn AL, Trivedi MH, O’Neal HA. Physical activity dose–response effects on outcomes of depression and anxiety. Med Sci Sports Exerc. 2001;33(6 Suppl):S587–97. discussion 609–10.PubMedCrossRef
87.
Salmon P. Effects of physical exercise on anxiety, depression, and sensitivity to stress: a unifying theory. Clin Psychol Rev. 2001;21(1):33–61.PubMedCrossRef
88.
89.
Dunstan DW et al. Too much sitting—a health hazard. Diabetes Res Clin Pract. 2012;97(3):368–76.PubMedCrossRef
90.
Beddhu S et al. Light-intensity physical activities and mortality in the United States general population and CKD subpopulation. Clin J Am Soc Nephrol. 2015;10(7):1145–53.PubMedPubMedCentralCrossRef
91.
Jelleyman C et al. The effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis. Obes Rev. 2015;16(11):942–61.PubMedCrossRef
92.•
Hamed N, Raoof N. Effect of high intensity interval training on diabetic obese women with polyneuropathy: a randomized controlled clinical trial. Phys Ther Rehabil. 2014;1(4):1. Compares high intensity interval training and moderate intensity aerobic exercise on pain and glucose tolerance in patients with polyneuropathy.
93.
Little JP et al. Low-volume high-intensity interval training reduces hyperglycemia and increases muscle mitochondrial capacity in patients with type 2 diabetes. J Appl Physiol (1985). 2011;111(6):1554–60.CrossRef
94.
Iellamo F et al. Matched dose interval and continuous exercise training induce similar cardiorespiratory and metabolic adaptations in patients with heart failure. Int J Cardiol. 2013;167(6):2561–5.PubMedCrossRef
95.
Fu TC et al. Aerobic interval training improves oxygen uptake efficiency by enhancing cerebral and muscular hemodynamics in patients with heart failure. Int J Cardiol. 2013;167(1):41–50.PubMedCrossRef
96.
Conraads VM et al. Aerobic interval training and continuous training equally improve aerobic exercise capacity in patients with coronary artery disease: the SAINTEX-CAD study. Int J Cardiol. 2015;179:203–10.PubMedCrossRef
97.
Sigal RJ et al. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006;29(6):1433–8.PubMedCrossRef
98.•
Kluding PM et al. Safety of aerobic exercise in people with diabetic peripheral neuropathy: single-group clinical trial. Phys Ther. 2015;95(2):223–34. Examines adverse events during moderate-intensity, supervised aerobic exercise in people with diabetic peripheral neuropathy. PubMedCrossRef
Metadata
Title
Exercise in Type 2 Diabetic Peripheral Neuropathy
Authors
Arwen A. Fuller
J. Robinson Singleton
A. Gordon Smith
Robin L. Marcus
Publication date
01-09-2016
Publisher
Springer US
Published in
Current Geriatrics Reports / Issue 3/2016
Electronic ISSN: 2196-7865
DOI
https://doi.org/10.1007/s13670-016-0177-6

Other articles of this Issue 3/2016

Current Geriatrics Reports 3/2016 Go to the issue

Physical Therapy and Rehabilitation (O Addison, Section Editor)

The Loss of Power and Need for Power Training in Older Adults

Hematology and Oncology (T Wildes, Section Editor)

Upper Extremity Exercise in Older Breast Cancer Survivors: Benefits of Dragon Boat Paddling

Hematology and Oncology (TM Wildes, Section Editor)

Psychosocial Health of Older Adults with Cancer: Clinical Interventions Promoting Meaning and Value-Driven Behavior

Hematology and Oncology (TM Wildes, Section Editor)

Assessment of physical function in geriatric oncology based on International Classification of Functioning, Disability and Health (ICF) framework

Hematology and Oncology (T Wildes, Section Editor)

Cognition and Cognitive Impairment in Older Adults with Cancer

Physical Therapy and Rehabilitation (O Addison, Section Editor)

The Effects of Performance Fatigability on Postural Control and Rehabilitation in the Older Patient
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits